| Search for content and authors |
|
|
| |
 |
dr Filip Stefaniak
|
| e-mail: | ***@celonpharma.com |
| phone: | +48-22-7517478 |
| fax: | |
| web: | |
| interest(s): | |
|
Affiliation: |
Celon Pharma Sp. z o.o. |
Participant: |
|
Publications: |
- Design and development of CPL-407-22 – novel, potent and selective JAK2 protein kinase inhibitor.
- Novel small molecule STAT3 inhibitors in cancer therapy.
|
